Cantourage Group SE
WKN: A3DSV0 | ISIN: DE000A3DSV01 | FSE: HIGH

Just five years after its founding, Cantourage has quickly established itself as a market leader in the European medical cannabis sector, consistently achieving substantial revenue growth year after year. By leveraging its asset-light strategy and cost efficiency, Cantourage achieved break-even in 2023

In preparation for cannabis legalisation in Germany, Cantourage went public in Autumn of 2022 to enable small and institutional investors to be part of a global growth industry. The company is listed on the Frankfurt Stock Exchange under the ticker “HIGH”.